Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction.
Valdes-Marquez E. et al, (2023), Eur J Prev Cardiol
Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease.
Clarke R. et al, (2023), Circ Res
Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.
Aragam KG. et al, (2022), Nat Genet
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries.
Mishra A. et al, (2022), Nature
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.
Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet (London, England), 400, 832 - 845
Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.
Clarke R. et al, (2022), Atherosclerosis, 354, 15 - 22
Stroke genetics informs drug discovery and risk prediction across ancestries
CHEN Z. et al, (2022), Nature
Multiplexed apolipoprotein profiling advances the assessment of residual lipid-related cardiovascular risk
Schmidt L. et al, (2022), CARDIOVASCULAR RESEARCH, 118
Multi-phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations.
Temprano-Sagrera G. et al, (2022), J Thromb Haemost, 20, 1331 - 1349
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur Heart J, 43, 1416 - 1424
CHALLENGES IN EXTRAPOLATION WHEN THERE ARE MULTIPLE HEALTH OUTCOMES
Willliam C. et al, (2022), VALUE IN HEALTH, 25, S358 - S358
The impact of atrial fibrillation and stroke risk factors on left atrial blood flow characteristics.
Spartera M. et al, (2021), Eur Heart J Cardiovasc Imaging, 23, 115 - 123
Are polygenic risk scores for systolic blood pressure and LDL-cholesterol associated with treatment effectiveness, and clinical outcomes among those on treatment?
Tapela NM. et al, (2021), Eur J Prev Cardiol
Robust estimates of heritable coronary disease risk in individuals with type 2 diabetes.
Grace C. et al, (2021), Genet Epidemiol
Genome-Wide Association Study of Peripheral Artery Disease.
van Zuydam NR. et al, (2021), Circ Genom Precis Med
Impact of ACLY on type 2 diabetes in UK Biobank: a Mendelian randomisation study
Stiby A. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3011 - 3011
Impact of adverse events on quality of life and hospital costs in secondary cardiovascular disease prevention
Lui NMJ. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3159 - 3159
Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort.
Clift AK. et al, (2021), Thorax